Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This is a phase IV, 2-year, multi-center, single arm and open-label study, evaluating the
efficacy and safety with using local manufactured adefovir dipivoxil in Chinese subjects with
HBeAg negative chronic hepatitis B